Clinical Trials Directory

Trials / Completed

CompletedNCT05152030

The Clinical Applicability of the 'TIB' Olfactory Test Device

Validation of the Local Applicability of the 'TIB' Olfactory Test Device in the Era of COVID-19

Status
Completed
Phase
Study type
Observational
Enrollment
180 (actual)
Sponsor
Taichung Veterans General Hospital · Academic / Other
Sex
All
Age
20 Years – 59 Years
Healthy volunteers
Accepted

Summary

The aim of this study was to evaluate the validity and test-retest reliability of the 'TIB' Olfactory Test Device, a new olfactory test tool developed by Top International Biotech, Taipei, and to determine its normative values. The olfactory function of 180 subjects was evaluated using both the traditional Chinese version of the University of Pennsylvania of Smell Identification Test (UPSIT-TC) and TIB. The subjects consisted of 60 healthy volunteers (normosmic group), 60 hyposmic patients, and 60 anosmic patients. The healthy volunteers were retested with the UPSIT-TC and TIB at an inter-test interval of at least 7 days. The cut-off scores of TIB among the different groups were determined by receiver operating characteristic curve.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TEST'TIB' Olfactory TestA new smell identification test, 'TIB' Olfactory Test Device (Top International Biotech, Taipei) has been developed in Taiwan. It consists of 16 tests with an odorant embedded in fragrant microcapsules positioned on a strip. The examinee scratches the strip to release the odorant. The released odorant is sniffed and the examinee identifies the odorant by choosing a name from a set of 4 odor descriptors. This process is then repeated with the next odorant on the strip.
DIAGNOSTIC_TESTTraditional Chinese version of the University of Pennsylvania of Smell Identification Test (UPSIT-TC)The University of Pennsylvania Smell Identification Test (UPSIT), which was developed at the University of Pennsylvania, is one of the most reliable and the most widely used olfactory test.The test consists of four 10-odorant booklets. Each odorant is embedded in 10 to 50 µm urea-formaldehyde polymer microencapsules fixed in a proprietary binder and positioned on a brown strip which is located at the bottom of each page of the test booklet.4 When the examinee takes the test, each of the 40 odorants is released by scratching the strip with a pencil tip. The released odorant is sniffed and the examinee identifies the odorant by choosing a name from a set of 4 odor descriptors.

Timeline

Start date
2020-11-01
Primary completion
2021-08-31
Completion
2021-09-16
First posted
2021-12-09
Last updated
2021-12-09

Locations

1 site across 1 country: Taiwan

Source: ClinicalTrials.gov record NCT05152030. Inclusion in this directory is not an endorsement.